Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Estudio de fase 1 del inhibidor de menina ziftomenib en combinación con quimioterapia en niños con leucemia aguda recidivante o resistente al tratamiento con reordenamientos de los genes KMT2A o NUP98, o con mutación en el gen NPM1

Contact

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio clínico de fase 3, aleatorizado, controlado con placebo y doble ciego para evaluar la eficacia y la seguridad de molnupiravir (MK-4482) en adultos no hospitalizados con COVID-19 y alto riesgo de progresión de la enfermedad

Contact
  • Protocol code: MK-4482-023
  • EudraCT code: No aplica
  • Pathology: Certes malalties infeccioses i parasitàries
  • Principal investigator:  Len Abad, Oscar
  • Research group:  Malalties infeccioses
  • Service: Infeccioses
  • Phase: Fase III
  • Recruiting: Closed
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A Phase 2a, Open-label, Multicenter, Platform Trial to Assessthe Safety, Tolerability, and Efficacy of Inebilizumab andBlinatumomab in Subjects With Select Autoimmune Diseases

Contact
  • Protocol code: 20240033
  • EudraCT code: No aplica
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Principal investigator:  Bestard Matamoros, Oriol
  • Research group:  Nefrologia i trasplantament renal
  • Service: Nefrologia
  • Phase: Fase II
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.
05/05/2025

2º Curso de atención al paciente quemado crítico.

Ubicació
Sala d’actes de la planta 1 del Pavelló Docent
Etiqueta
Curs Aula
27/03/2025

Per motius aliens se SUSPÈN- Vall d'Hebron Talks by VHIR 'Modular and adaptive dendrimer nanosystems for biomedical applications'

Ubicació
Boardroom of the VHIR Edifici Central (Floor 0)
Etiqueta
Vall d'Hebron Talks by VHIR
18/03/2025

Defensa de Tesi 'Association between the degree of immunosuppression measured by nuclear factor of activated T cells-regulated genes and cytomegalovirus infection in lung transplant recipients'
Etiqueta
Tesis
12/03/2025

Vall d'Hebron Talks by VHIR 'Molecular insights into ovarian endometriosis: (PHOSPHO) proteomic profiling of endometriomas for heterogeneity and recurrence characterization'
Ubicació
Boardroom of the VHIR Edifici Central (Floor 0)
Etiqueta
Vall d'Hebron Talks by VHIR
25/03/2025

Defensa de Tesi 'Valoració de criteris diagnòstics i predictors d'esdeveniments en no compactació del ventricle esquerre'
Ubicació
Aula 114 del Mòdul Sud de la Unitat Docent de Vall d'Hebron
Etiqueta
Tesis
21/03/2025

Defensa de Tesi 'ALPHA-Synuclein and Neuromelanin Interplay: unravelling its role in the pathophysiology of Parkinson disease'
Ubicació
Sala d'actes de l'Edifici Central del VHIR (Planta 0)
Etiqueta
Tesis
14/03/2025

Jornada Dia Mundial de l'Endometriosi
Ubicació
Sala d'actes de l'Edifici Central del VHIR (Planta 0)
Etiqueta
Jornades
Subscribe to